Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 09 06 2020
revised: 26 08 2020
accepted: 07 09 2020
pubmed: 18 11 2020
medline: 29 12 2020
entrez: 17 11 2020
Statut: ppublish

Résumé

A novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing an international outbreak of respiratory illness described as coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects human cells by binding to angiotensin-converting enzyme 2. Small studies suggest that renin-angiotensin system (RAS) blockers may upregulate the expression of angiotensin-converting enzyme 2, affecting susceptibility to SARS-CoV-2. This may be of great importance considering the large number of patients worldwide who are treated with RAS blockers, and the well-proven clinical benefit of these treatments in several cardiovascular conditions. In contrast, RAS blockers have also been associated with better outcomes in pneumonia models, and may be beneficial in COVID-19. This review sought to analyse the evidence regarding RAS blockers in the context of COVID-19 and to perform a pooled analysis of the published observational studies to guide clinical decision making. A total of 21 studies were included, comprising 11,539 patients, of whom 3417 (29.6%) were treated with RAS blockers. All-cause mortality occurred in 587/3417 (17.1%) patients with RAS blocker treatment and in 982/8122 (12.1%) patients without RAS blocker treatment (odds ratio 1.00, 95% confidence interval 0.69-1.45; P=0.49; I

Identifiants

pubmed: 33199208
pii: S1875-2136(20)30219-9
doi: 10.1016/j.acvd.2020.09.002
pmc: PMC7580526
pii:
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Angiotensin-Converting Enzyme Inhibitors 0
Peptidyl-Dipeptidase A EC 3.4.15.1

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

797-810

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Références

N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
N Engl J Med. 2001 Sep 20;345(12):851-60
pubmed: 11565517
Circ Res. 2017 Jun 23;121(1):43-55
pubmed: 28512108
Am J Hypertens. 2020 Oct 21;33(10):944-948
pubmed: 32511678
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Biochemistry (Mosc). 2000 Dec;65(12):1337-45
pubmed: 11173502
Diabetes Care. 2001 Dec;24(12):2091-6
pubmed: 11723089
Eur Heart J. 2020 Jun 7;41(22):2058-2066
pubmed: 32498076
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Clin Exp Hypertens. 2020 Nov 16;42(8):738-742
pubmed: 32569491
N Engl J Med. 2020 Jun 18;382(25):2441-2448
pubmed: 32356628
N Engl J Med. 1992 Sep 3;327(10):685-91
pubmed: 1463530
J Am Coll Cardiol. 2020 Jul 21;76(3):268-276
pubmed: 32470515
Lancet. 1999 Feb 20;353(9153):611-6
pubmed: 10030325
Lancet. 2019 Jan 5;393(10166):61-73
pubmed: 30429050
N Engl J Med. 1992 Sep 3;327(10):669-77
pubmed: 1386652
Lancet. 1993 Oct 2;342(8875):821-8
pubmed: 8104270
J Biol Chem. 2005 Aug 26;280(34):30113-9
pubmed: 15983030
FEBS Lett. 2002 Dec 4;532(1-2):107-10
pubmed: 12459472
Diabetes. 2008 Apr;57(4):1018-25
pubmed: 18235039
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Circulation. 2016 Apr 5;133(14):1426-8
pubmed: 26399660
Cardiovasc Res. 2020 Aug 1;116(10):1688-1699
pubmed: 32293003
N Engl J Med. 1991 Aug 1;325(5):303-10
pubmed: 2057035
Clin Infect Dis. 2020 Nov 19;71(16):2121-2128
pubmed: 32442285
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JACC Heart Fail. 2019 Jan;7(1):1-12
pubmed: 30414818
Regul Pept. 2011 Jan 17;166(1-3):90-7
pubmed: 20854846
N Engl J Med. 1991 Aug 1;325(5):293-302
pubmed: 2057034
N Engl J Med. 1987 Jun 4;316(23):1429-35
pubmed: 2883575
Emerg Microbes Infect. 2020 Dec;9(1):757-760
pubmed: 32228222
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Circ Res. 2010 Oct 1;107(7):888-97
pubmed: 20671240
Hypertension. 2014 Dec;64(6):1368-1375
pubmed: 25225202
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
N Engl J Med. 1992 Sep 3;327(10):678-84
pubmed: 1495520
J Hypertens. 1989 Dec;7(12):933-6
pubmed: 2560787
Hypertension. 1998 Sep;32(3):387-92
pubmed: 9740600
Lancet. 1997 Jun 28;349(9069):1857-63
pubmed: 9217756
Hypertension. 2004 May;43(5):970-6
pubmed: 15007027
Am J Hypertens. 2015 Jan;28(1):15-21
pubmed: 24842388
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
Lancet. 2003 Sep 6;362(9386):767-71
pubmed: 13678869
Lancet. 2003 Sep 6;362(9386):782-8
pubmed: 13678872
Eur Heart J. 2020 May 14;41(19):1801-1803
pubmed: 32196087
Diabetes Care. 2020 Jul;43(7):1399-1407
pubmed: 32409498
Lancet. 1999 Nov 20;354(9192):1751-6
pubmed: 10577635
N Engl J Med. 2003 Nov 13;349(20):1893-906
pubmed: 14610160
Cardiovasc Res. 2007 Jul 1;75(1):29-39
pubmed: 17499227
JAMA. 2002 Dec 18;288(23):2981-97
pubmed: 12479763
J Cardiovasc Dev Dis. 2019 Mar 29;6(2):
pubmed: 30934934
Circ Heart Fail. 2009 Sep;2(5):446-55
pubmed: 19808375
Eur Heart J. 2006 Oct;27(19):2338-45
pubmed: 16963472
N Engl J Med. 2001 Dec 6;345(23):1667-75
pubmed: 11759645
Nat Rev Cardiol. 2020 May;17(5):313
pubmed: 32231328
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Hypertension. 2020 Aug;76(2):e10-e12
pubmed: 32383626
Lancet. 1995 Mar 18;345(8951):669-85
pubmed: 7661937
N Engl J Med. 2001 Sep 20;345(12):861-9
pubmed: 11565518
J Am Coll Cardiol. 1993 Nov 15;22(6):1557-63
pubmed: 8227822
Am J Nephrol. 2009;29(6):524-31
pubmed: 19077419
Lancet. 2002 Mar 23;359(9311):1004-10
pubmed: 11937179
Eur J Clin Invest. 2009 Jul;39(7):618-25
pubmed: 19453650
Hypertension. 2020 Aug;76(2):366-372
pubmed: 32564693
Cardiology. 2017;137(2):121-125
pubmed: 28376504
J Am Heart Assoc. 2017 Feb 11;6(2):
pubmed: 28189999
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Int J Pept. 2012;2012:256294
pubmed: 22536270
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
JAMA Cardiol. 2020 Jul 1;5(7):825-830
pubmed: 32324209
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14
pubmed: 18490652
Front Med. 2020 Oct;14(5):601-612
pubmed: 32621202
Biochem J. 2004 Oct 1;383(Pt 1):45-51
pubmed: 15283675
Clin Exp Hypertens. 2020 Oct 2;42(7):656-660
pubmed: 32404011
Eur Heart J. 2020 May 14;41(19):1821-1829
pubmed: 32383763
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Am Coll Cardiol. 1997 Aug;30(2):400-5
pubmed: 9247511
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
JAMA Cardiol. 2020 Sep 1;5(9):1020-1026
pubmed: 32936273
Kidney Int. 2005 Nov;68(5):2189-96
pubmed: 16221218
Eur J Heart Fail. 2020 Jun;22(6):967-974
pubmed: 32485082
Int Heart J. 2009 Jul;50(4):501-12
pubmed: 19609054
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Am J Pathol. 2007 Apr;170(4):1136-47
pubmed: 17392154
Amino Acids. 2015 Apr;47(4):693-705
pubmed: 25534429
N Engl J Med. 2020 Jun 18;382(25):2431-2440
pubmed: 32356627
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
N Engl J Med. 2004 Nov 11;351(20):2058-68
pubmed: 15531767
N Engl J Med. 2000 Jan 20;342(3):145-53
pubmed: 10639539
N Engl J Med. 2008 Dec 4;359(23):2456-67
pubmed: 19001508
Lancet. 2000 Jan 22;355(9200):253-9
pubmed: 10675071
Arch Intern Med. 2006 Mar 27;166(6):659-66
pubmed: 16567606
Lancet. 2003 Sep 6;362(9386):777-81
pubmed: 13678871
J Card Fail. 2020 May;26(5):370
pubmed: 32439095
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Biol Chem. 2000 Oct 27;275(43):33238-43
pubmed: 10924499
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Am J Hypertens. 1999 Dec;12(12 Pt 3):189S-194S
pubmed: 10619571
Drug Dev Res. 2020 Aug;81(5):537-540
pubmed: 32129518
Ann Transl Med. 2020 Apr;8(7):430
pubmed: 32395474
Clin Infect Dis. 2020 Jul 28;71(15):899-901
pubmed: 32339215
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Am J Cardiol. 1982 Apr 21;49(6):1497-501
pubmed: 6803564
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Circulation. 1999 Dec 7;100(23):2312-8
pubmed: 10587334
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Hum Hypertens. 2002 Aug;16 Suppl 3:S34-41
pubmed: 12140726
J Cardiovasc Pharmacol. 2015 Mar;65(3):226-32
pubmed: 25636068
N Engl J Med. 1995 Dec 21;333(25):1670-6
pubmed: 7477219
Trends Pharmacol Sci. 2004 Jun;25(6):291-4
pubmed: 15165741
J Hypertens. 2020 May;38(5):781-782
pubmed: 32195824
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H958-H970
pubmed: 30707614
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Hypertension. 2020 Jul;76(1):51-58
pubmed: 32348166
J Pathol. 2006 Nov;210(3):288-97
pubmed: 17031779
Lancet. 2017 Dec 9;390(10112):2549-2558
pubmed: 29102084
Lancet. 2003 Sep 6;362(9386):772-6
pubmed: 13678870

Auteurs

Mathieu Kerneis (M)

Sorbonne université, ACTION Study Group, INSERM UMRS 1166, institute of cardiology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Arnaud Ferrante (A)

Sorbonne université, ACTION Study Group, INSERM UMRS 1166, institute of cardiology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Paul Guedeney (P)

Sorbonne université, ACTION Study Group, INSERM UMRS 1166, institute of cardiology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Eric Vicaut (E)

ACTION Study Group, unité de recherche clinique, hôpital Saint-Louis, AP-HP, université de Paris, 75010 Paris, France.

Gilles Montalescot (G)

Sorbonne université, ACTION Study Group, INSERM UMRS 1166, institute of cardiology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: gilles.montalescot@psl.aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH